Section 232 pharmaceutical exemption for clinical trials and research
From September 29, 2026, pharmaceutical articles and ingredients used solely in clinical trials, research and development or other non-commercial applications pay no Section 232 pharmaceutical duty. Inactive ingredients and excipients are no longer pharmaceutical articles, and unpatented animal health products count as generics.